apollo
0
  1. Home
  2. Medicine
  3. Kyprolis 30 mg Injection 1's

48 Hrs returnable
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

CARFILZOMIB-30MG

Manufacturer/Marketer :

Dr Reddy's Laboratories Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

Therapeutic Class

CHEMOTHERAPY

Country of origin

INDIA

Manufacturer/Marketer address

Dr. Reddy'S Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, India
Other Info - KYP0003

FAQs

Kyprolis 30 mg Injection contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.

No, it is unsafe to father a child while taking Kyprolis 30 mg Injection. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Kyprolis 30 mg Injection.

Based on the medical condition, Kyprolis 30 mg Injection may be given alone or together with other medicines used to treat multiple myeloma.

Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.

Kyprolis 30 mg Injection can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Caution

Avoid alcohol consumption while on treatment with Kyprolis 30 mg Injection.

bannner image

Pregnancy

Unsafe

Kyprolis 30 mg Injection should not be taken during pregnancy as it might cause fetal harm. Inform your doctor immediately if you are conceiving while on therapy.

bannner image

Breast Feeding

Unsafe

Do not breastfeed while you are receiving Kyprolis 30 mg Injection and for two weeks after your final dose.

bannner image

Driving

Caution

Kyprolis 30 mg Injection may cause fatigue, dizziness, fainting, and/or a drop in blood pressure. So, if you have any of these symptoms while in therapy, you should not operate machinery or drive a car.

bannner image

Liver

Caution

Extreme caution is exercised while using Kyprolis 30 mg Injection in patients with liver impairment. Inform your doctor if you have liver impairment. Your doctor monitors liver enzymes and withholds dosing if suspected.

bannner image

Kidney

Caution

Limited information is available. Please inform your doctor before prescribing Kyprolis 30 mg Injection if you have kidney impairment. Your doctor will weigh the benefits and potential risks before prescribing Kyprolis 30 mg Injection.

bannner image

Children

Caution

The safety and effectiveness of Kyprolis 30 mg Injection in pediatric patients have not been established.

icon image

Keep Refrigerated. Do not freeze.

About Kyprolis 30 mg Injection

Kyprolis 30 mg Injection belongs to the group of proteasome inhibitors (anti-cancer medicines). It is used alone and in combination with other medications to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with other medicines. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer that affects several areas of the body, such as the spine, skull, pelvis, and ribs.

Kyprolis 30 mg Injection contains Carfilzomib, which suppresses proteasomes that prevent protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.

Kyprolis 30 mg Injection is administered in a hospital setting by a physician qualified by training and experience to administer cancer chemotherapeutic agents. Sometimes, you may experience common side effects, such as fatigue (feeling overtired), anaemia, nausea, thrombocytopenia (low platelet level), dyspnea (feeling short of breath), diarrhoea, and pyrexia (fever). Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if any of these side effects persist or worsen.

Before taking the Kyprolis 30 mg Injection, inform your doctor about all your allergic or hypersensitivity reactions to medicines or food. Kyprolis 30 mg Injection can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant while undergoing therapy and for several months afterwards. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment since it is unknown whether this medication passes into breast milk. Do not skip any laboratory checks because Thrombocytopenia, Hepatic Toxicity and Hepatic Failure may occur. If it happens, reduce or interrupt dosing as clinically indicated.

Uses of Kyprolis 30 mg Injection

Multiple Myeloma

Medicinal Benefits Mweb

Medicinal Benefits

Carfilzomib, a proteasome inhibitor, is present in Kyprolis 30 mg Injection. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.

Directions for Use

Kyprolis 30 mg Injection will be administered in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents.

Side Effects of Kyprolis 30 mg Injection

  • Fatigue (feeling overtired)
  • Anaemia (lack of blood)
  • Nausea
  • Thrombocytopenia (low platelet level)
  • Dyspnea (feeling short of breath)
  • Diarrhea
  • Pyrexia (fever)
  • Increased risk of infection
  • Breathlessness and looking pale
  • Bruising, bleeding gums or nosebleeds
  • Low potassium levels in the blood
  • Decreased appetite
  • Difficulty sleeping (insomnia)
  • Headache and dizziness
  • Numbness or tingling in hands and feet
  • High blood pressure
  • Shortness of breath
  • Cough
  • Constipation
  • Feeling sick or being sick
  • Tummy (abdomen) Pain
  • Joint, muscle or bone pain

Drug Warnings

Before taking Kyprolis 30 mg Injection, inform your doctor about your medical history and other medications you are currently taking to rule out any potential negative effects. Avoid taking Kyprolis 30 mg Injection if you are pregnant or breastfeeding or allergic to any component present in Kyprolis 30 mg Injection. Both women and men using this Kyprolis 30 mg Injection should use birth control to avoid pregnancy. Inform your doctor right away if you or your partner become pregnant during treatment with Kyprolis 30 mg Injection. Inform your doctor if you have a history of heart failure and ischemia, Pulmonary Hypertension, Thrombocytopenia, low blood pressure or hepatic toxicity; your doctor will closely monitor and manage it. Carfilzomib injection may induce serious or life-threatening responses for up to 24 hours following administration. Before each dose of carfilzomib, you will be given specific drugs to assist in preventing a reaction. If you develop any of the following symptoms after your treatment, contact your doctor right away: fever, chills, joint or muscle pain, flushing or swelling of the face, swelling or tightening of the throat, vomiting, weakness, shortness of breath, disorientation or fainting, or chest tightness or pain.

Drug-Drug Interactions

verifiedApollotooltip

Drug-Drug Interactions

Login/Sign Up

How does the drug interact with Kyprolis 30 mg Injection:
Taking Kyprolis 30 mg Injection with tamoxifen may increase the risk of blood clots. The risk is also increased with age, cigarette smoking, high blood pressure, or high cholesterol.

How to manage the interaction:
Although taking tamoxifen and Kyprolis 30 mg Injection together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness or swelling in an arm or leg, and numbness or weakness on one side of the body. Do not stop using any medications without consulting doctor.
How does the drug interact with Kyprolis 30 mg Injection:
Kyprolis 30 mg Injection can cause serious blood clots and taking it alongside estradiol may enhance the risk.

How to manage the interaction:
Co-administration of Estradiol with Kyprolis 30 mg Injection can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms like chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness, or swelling in an arm or leg, or numbness or weakness on one side of the body, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Kyprolis 30 mg Injection:
Combining Adalimumab with Kyprolis 30 mg Injection can increase the risk of infections.

How to manage the interaction:
Co-administration of Kyprolis 30 mg Injection with Adalimumab can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away infection, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, pain or burning during urination. Do not stop using any medications without first talking to your doctor.
How does the drug interact with Kyprolis 30 mg Injection:
Coadministration of Eltrombopag with Kyprolis 30 mg Injection can increase the risk or severity of blood clots that can lead to complications such as heart attack, pulmonary embolism (blockage of an artery in the lung), and stroke.

How to manage the interaction:
Although taking Eltrombopag and Kyprolis 30 mg Injection together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any of these signs, chest pain, difficulty breathing, coughing up blood, sudden vision loss, pain, redness, swelling in an arm or leg, or weakness on one side of your body it's important to contact a doctor right away. Do not stop using any medications without a doctor's advice.
How does the drug interact with Kyprolis 30 mg Injection:
Combining Infliximab with Kyprolis 30 mg Injection can increase the risk or severity of developing serious infections.

How to manage the interaction:
Although taking Kyprolis 30 mg Injection and Infliximab together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms like fever, chills, diarrhea, sore throat, muscle aches, difficulty breathing, losing weight, or pain or burning when you pee, it's important to contact a doctor right away. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Kyprolis 30 mg Injection:
Combining Kyprolis 30 mg Injection with danazol may increase the risk of liver problems.

How to manage the interaction:
Although there is a possible interaction between Danazol and Kyprolis 30 mg Injection, you can take these medicines together if prescribed by your doctor. However, if you experience chest pain; shortness of breath; difficulty breathing; coughing up blood; sudden loss of vision; pain, redness or swelling in an arm or leg; and numbness or weakness on one side of the body, contact a doctor right away. Do not discontinue any medications without first consulting your doctor.
How does the drug interact with Kyprolis 30 mg Injection:
Taking Prasterone with Kyprolis 30 mg Injection can increase the risk of clotting.

How to manage the interaction:
Co-administration of Prasterone with Kyprolis 30 mg Injection can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience sudden loss of eyesight, chest pain, breathing difficulties, coughing up blood, pain, redness, or swelling in an arm or leg, and numbness or weakness on one side of the body, consult a doctor, immediately. Do not stop using any medications without a doctor's advice.
How does the drug interact with Kyprolis 30 mg Injection:
Co-administration of Kyprolis 30 mg Injection with Tranexamic acid can increase the risk of blood clots.

How to manage the interaction:
Taking Kyprolis 30 mg Injection with tranexamic acid is not recommended due to its increased effects, however, it can be taken only if a doctor has advised it. If you experience symptoms such as chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, and numbness or weakness on one side of the body contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Kyprolis 30 mg Injection:
The combined use of Testosterone and Kyprolis 30 mg Injection can increase the risk of blood clots.

How to manage the interaction:
Co-administration of Testosterone and Kyprolis 30 mg Injection can lead to an interaction, but it can be taken if your doctor advises. However, if you experience any symptoms like chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness or swelling in an arm or leg, and numbness or weakness on one side of the body, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
CarfilzomibAminocaproic acid
Severe
How does the drug interact with Kyprolis 30 mg Injection:
Coadministration of Aminocaproic acid and Kyprolis 30 mg Injection can increase the risk of developing blood clots.

How to manage the interaction:
Co-administration of Kyprolis 30 mg Injection with Aminocaproic acid can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience any symptoms, such as chest pain, shortness of breath, redness or swelling in an arm or leg, or weakness, contact a doctor right away. Do not discontinue any medications without consulting a doctor.

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Food Interactions

Login/Sign Up

Drug-Diseases Interactions

verifiedApollotooltip
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Diseases Interactions

Login/Sign Up

Drug-Drug Interactions Checker List

  • ADALIMUMAB
  • BARICITINIB
  • FINGOLIMOD
  • BCG VACCINE
  • DENGUE VACCINE
  • CLOZAPINE
  • METHYLTESTOSTERONE

Habit Forming

No

Special Advise

  • Pregnancy testing is recommended for females of reproductive potential prior to initiating treatment with Kyprolis 30 mg Injection.
  • Keep all appointments with your doctor and the laboratory. Your doctor will order laboratory tests before, during and after your treatment to check your body's response to Kyprolis 30 mg Injection to see if your blood cells are affected by this drug.
  • Do not donate sperm during treatment with Kyprolis 30 mg Injection and for three months after your last dose.

Diet & Lifestyle Advise

  • De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
  • Performing yoga may also help in improving both physical and mental health.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugars.

Kyprolis 30 mg Injection Substitute

Substitutes safety advice

Have a query?

Buy Now
Add to Cart